InvestorsHub Logo

DewDiligence

09/13/18 3:31 PM

#17152 RE: DewDiligence #17046

ABT—379th consecutive qrtly dividend (&another all-time high):

https://finance.yahoo.com/news/abbott-declares-379th-consecutive-quarterly-151400449.html

DewDiligence

09/23/18 6:07 PM

#17208 RE: DewDiligence #17046

ABT’s MitraClip meets all endpoints in secondary mitral regurgitation:

https://finance.yahoo.com/news/landmark-study-shows-treatment-abbotts-172000535.html

Secondary mitral regurgitation is a considerably larger market than MitraClip’s approved indication in primary mitral regurgitation, so this trial could move the needle even for a company as large as ABT.

DewDiligence

10/15/18 11:28 AM

#17336 RE: DewDiligence #17046

ABT names COO—likely (but announced) successor to CEO, Miles White:

https://finance.yahoo.com/news/abbott-names-robert-b-ford-123000722.html

White has ABT’s CEO since 1998—the longest CEO tenure of any large-cap healthcare company.